Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  L'Oreal    OR   FR0000120321

L'OREAL (OR)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
02/20/2017 02/21/2017 02/22/2017 02/23/2017 02/24/2017 Date
172.65(c) 173.45(c) 176.5(c) 176.9(c) 176.85 Last
711 588 631 626 975 577 613 702 66 944 Volume
-1.96% +0.46% +1.76% +0.23% -0.03% Change
More quotes
Financials (€)
Sales 2017 27 584 M
EBIT 2017 4 940 M
Net income 2017 3 825 M
Finance 2017 1 340 M
Yield 2017 2,02%
Sales 2018 28 952 M
EBIT 2018 5 247 M
Net income 2018 4 077 M
Finance 2018 2 507 M
Yield 2018 2,19%
P/E ratio 2017 25,75
P/E ratio 2018 24,22
EV / Sales2017 3,54x
EV / Sales2018 3,33x
Capitalization 99 025 M
More Financials
Company
L'Oréal SA engages in the manufacture and sale of beauty and hair products.It operates through the following segments: Professional Products, Consumer Products, L'Oréal Luxury, and Active Cosmetics.The Professional Products segment manufactures products which are used and sold in hair salons.The... 
Sector
Personal Products
Calendar
02/24 | 03:30pmPresentation
More about the company
Surperformance© ratings of L'Oreal
Trading Rating : Investor Rating :
More Ratings
Latest news on L'OREAL
02/23 L'OREAL : Cheryl Cole shows off baby bump in charity video
02/21 L'ORÉAL : SHARE BUYBACK - From February 13th to February 17th 2017
02/20 L'OREAL : L’Oreal State-of-the-Art Facility with €50 m investments
02/17 L'OREAL : Disposable Shampoo Market 2017 - Head & Shoulders, Pantene, CLEAR, VS,..
02/17 Cosmetic Product Market 2017 - L Oreal, the Procter & Gamble, Unilever, Shise..
02/16 NESTLE : CEO says any change to L'Oreal stake would have to be done very careful..
02/15 MACY : Sickle cell aside, Chesapeake woman making her way in NYC modeling scene
02/14 L'OREAL : Les ventes de L’Oréal ont progressé en 2016
02/11 MACY : Sickle cell aside, Chesapeake woman making her way in NYC modeling scene
02/10 UK's Elementis to buy SummitReheis to grow personal care chemicals
More news
Sector news : Cosmetics & Perfumes
02/23 Buffett expected to tout passive investing in Berkshire annual letter
02/23DJUnilever Launches Review After Rejecting Kraft Heinz Offer--3rd Update
02/22 Unilever, Lloyds help FTSE edge higher
02/22DJUnilever Launches Review After Rejecting Kraft Heinz Offer--2nd Update
02/22DJUnilever Launches Review After Rejecting Kraft Heinz Offer--Update
More sector news : Cosmetics & Perfumes
4-Traders Strategies on L'OREAL 
02/16In an accumulation phase
2016Helped by a technical support level
More Strategies
Latest Tweets
02/23#Cheryl debuts HUGE baby bump alongside Helen Mirren in star-studded L’Oreal ..
1
02/23L'Oreal unveils 'All Worth It' campaign with @PrincesTrust   
02/23#Cheryl debuts HUGE baby bump alongside Helen Mirren in star-studded L’Oreal ..
4
02/23L'Oréal Paris and The Prince's Trust "All worth it" by McCann London  
02/23#Cheryl debuts HUGE baby bump alongside Helen Mirren in star-studded L’Oreal ..
2
More tweets
Qtime:97
News from SeekingAlpha
02/10 L'Oréal's (LRLCY) CEO Jean-Paul Agon on Full Year 2016 Results - Earnings Cal..
02/09 L'Oreal Co. ADR reports FY results
02/08 WALL STREET BREAKFAST : Brexit Bill To Clear Major Hurdle
02/08 L'Oreal explores sale of The Body Shop
02/05 ESTEE LAUDER : Is A Reversal On Its Way?
Advertisement
Chart L'OREAL
Duration : Period :
L'Oreal Technical Analysis Chart | OR | FR0000120321 | 4-Traders
Full-screen chart
Technical analysis trends L'OREAL
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 28
Average target price 177 €
Spread / Average Target 0,20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jean-Paul Agon Chairman, Chief Executive Officer & Executive VP
Barbara Lavernos Executive Vice President-Operations
Christian Mulliez Chief Financial Officer & EVP-Administration
Laurent Attal Executive Vice President-Research & Innovation
Martha Crawford-Heitzmann SVP-Advanced Research & Scientific Directorate
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
L'OREAL1.79%104 858
KAO CORP2.94%25 482
AMOREPACIFIC CORP--.--%16 428
COTY INC2.89%14 061
SHISEIDO COMPANY, LIMI..-0.39%10 449
AMOREPACIFIC GROUP--.--%9 104
More Results